DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria

Information source: University Ghent
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Malaria

Intervention: Administration of quinine sulphate taste-masked pellets (Drug)

Phase: Phase 2

Status: Recruiting

Sponsored by: University Ghent

Official(s) and/or principal investigator(s):
Luc Van Bortel, MD, PhD, Principal Investigator, Affiliation: University Hospital, Ghent

Overall contact:
Jean-Paul Remon, PhD, Phone: 0032/(0)9/264.80.54, Email: jeanpaul.remon@UGent.be

Summary

No pediatric formulations of quinine exist. Therefore, quinine tablets are broken into 2 or 4 parts, according to the body weight. Based on the body weight, 1/2 or 1/4 a tablet is administered to the child.

At this moment, quinine sulphate pellets are developed. These pellets enable an adequate dosing according to the body weight.

56 children with malaria will be dosed every 8 hours during 7 days with 10-15mg/kg body weight.

Clinical Details

Official title: Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria

Study design: Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Primary outcome:

Clocktime when child has had no fever for minimal 48h (< 37,5°C)

Parasitemy

Secondary outcome: Plasma concentration of quinine at day 4 between first and second administration

Eligibility

Minimum age: 6 Months. Maximum age: 59 Months. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Malaria (falciparium malaria, uncomplicated)

- Informed consent

Exclusion Criteria:

-

Locations and Contacts

Jean-Paul Remon, PhD, Phone: 0032/(0)9/264.80.54, Email: jeanpaul.remon@UGent.be

Centre Hospitalier De Butare, Butare, Rwanda; Recruiting
Jean-Paul Remon, PhD, Phone: 0032/(0)9/264.80.54, Email: jeanpaul.remon@UGent.be
Marc Twagirumukiza, MD, Principal Investigator
Additional Information

Website University Hospital Ghent


Last updated: December 19, 2007

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008